Given the anti-inflammatory effects of ABA in neuroinflammation and Alzheimer’s disease in combination with its capacity to activate PPARγ, we hypothesized that ABA could improve remyelination through modulation of macrophage phenotype and neuroinflammation in experimental models of MS. This evidence concerns the gene PPARG and myeloid sarcoma.